Literature DB >> 7977983

Lymph node prognostic factors in head and neck squamous cell carcinomas.

G Mamelle1, J Pampurik, B Luboinski, R Lancar, A Lusinchi, J Bosq.   

Abstract

BACKGROUND: This retrospective study included 914 patients who underwent a lymph node dissection at our institute between 1980 and 1985. The primary tumor sites were oral cavity, 287; hypopharynx, 249; larynx, 247; and oropharynx, 131. PATIENTS AND METHODS: On the basis of anatomic considerations, the sentinel nodes for well-lateralized oral cavity tumors were defined as homolateral levels I, II, and III; for oropharyngeal, hypopharyngeal, and laryngeal tumors, the sentinel nodes were defined as levels II and III. We took into account the ipsilateral side of the neck for well-lateralized tumors, and both sides for medium or large tumors. For clinically positive nodes of more than 3 cm, a radical neck dissection was performed. Other patients underwent a selective neck dissection on sentinel nodes, with immediate pathologic evaluation. Modified radical neck dissections with contralateral selective dissection were performed when frozen sections were positive. Patients with positive nodes were given postoperative radiotherapy.
RESULTS: The prognostic factors studied, using the Cox survival model adjusted on the primary tumor site, surprisingly showed a nonsignificant value for extracapsular spread (P = 0.09), and a significant value for the number of positive nodes (P < 0.001) and for the positive node in or out of the sentinel node sites (P < 0.001). Although the node location factor can be used instead of positive node in or out of the sentinel node site, it has a less significant prognostic value.
CONCLUSIONS: The most significant prognostic factors are the site of the positive node in or out of the sentinel node and the number of positive nodes; and a more accurate approach can be obtained by combining both factors. Node location in the upper or lower neck remains a substitute prognostic factor for the site of the positive node in or out of the sentinel node.

Entities:  

Mesh:

Year:  1994        PMID: 7977983     DOI: 10.1016/s0002-9610(05)80109-6

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  59 in total

1.  Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo.

Authors:  Yong Liu; Changyun Yu; Yuanzheng Qiu; Donghai Huang; Xiaojuan Zhou; Xin Zhang; Yongquan Tian
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-16       Impact factor: 4.553

2.  Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma.

Authors:  Yoshihiro Morita; Kenji Hata; Masako Nakanishi; Tetsuji Omata; Nobuo Morita; Yoshiaki Yura; Riko Nishimura; Toshiyuki Yoneda
Journal:  Clin Exp Metastasis       Date:  2015-08-29       Impact factor: 5.150

Review 3.  Role of sentinel node biopsy in the management and staging of the N0 neck.

Authors:  Gary L Ross; Taimur Shoaib
Journal:  Odontology       Date:  2005-09       Impact factor: 2.634

4.  Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.

Authors:  Lei Huang; Odile David; Robert J Cabay; Klara Valyi-Nagy; Virgilia Macias; Rong Zhong; Barry Wenig; Lawrence Feldman; Ralph Weichselbaum; Michael T Spiotto
Journal:  Clin Cancer Res       Date:  2018-12-20       Impact factor: 12.531

5.  Predictive factors for late cervical metastasis in stage I and II squamous cell carcinoma of the lip.

Authors:  Norberto K Kavabata; Décio N Caly; Ting H Ching; Antonio J Gonçalves; Luis P Kowalski; Cláudio R Cernea
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-06-04       Impact factor: 2.503

6.  Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma.

Authors:  Volkert B Wreesmann; Nora Katabi; Frank L Palmer; Pablo H Montero; Jocelyn C Migliacci; Mithat Gönen; Diane Carlson; Ian Ganly; Jatin P Shah; Ronald Ghossein; Snehal G Patel
Journal:  Head Neck       Date:  2015-10-30       Impact factor: 3.147

7.  Expression of the CXCL12/CXCR4 chemokine axis predicts regional control in head and neck squamous cell carcinoma.

Authors:  Xavier León; Santiago Diez; Jacinto García; Joan Lop; Anna Sumarroca; Miquel Quer; Mercedes Camacho
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-21       Impact factor: 2.503

8.  A critical evaluation of lymph node ratio in head and neck cancer.

Authors:  M de Ridder; C C M Marres; L E Smeele; M W M van den Brekel; M Hauptmann; A J M Balm; M L F van Velthuysen
Journal:  Virchows Arch       Date:  2016-09-18       Impact factor: 4.064

9.  What is the role of sentinel lymph node biopsy in the management of oral cancer in 2010?

Authors:  Francisco J Civantos; Sandro J Stoeckli; Robert P Takes; Julia A Woolgar; Remco de Bree; Vinidh Paleri; Kenneth O Devaney; Alessandra Rinaldo; Carl E Silver; Vanni Mondin; Jochen A Werner; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-03-05       Impact factor: 2.503

10.  Reduced impact of nodal metastases as a prognostic factor for tonsil cancer in the HPV era.

Authors:  Peter M Vila; Chaz L Stucken; Luc G T Morris; Marshall R Posner; Eric M Genden; Paolo Boffetta; Andrew G Sikora
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-05       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.